Cynapsus Therapeutic (CYNAF) 0.9600 $CYNAF Cynapsus

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Cynapsus Therapeutic (CYNAF) 0.9600 $CYNAF

Cynapsus Therapeutics Inc. : Announces Proposed Public Offering in the United States, Listing on NASDAQ and Share Consolidation
GlobeNewswire - Fri May 15, 4:33PM CDT
Cynapsus Therapeutics Inc. (TSX: CTH) (OTCQX: CYNAF) announced today the filing of a registration statement with the US Securities and Exchange Commission relating to a public offering in the United States of its common shares and the filing of an application to list on the NASDAQ Capital Market. The timing, number of shares and price per share of the proposed offering have not yet been determined. Cynapsus also announced an amendment to the Company's articles to consolidate the issued and outstanding common shares of the Company on the basis of one post-consolidation common share for 16 pre-consolidation common shares to facilitate the proposed listing on NASDAQ, as previously approved by the shareholders of the Company.
CTH.TO: 21.97 (-0.97)

Cynapsus Therapeutics Announces Proposed Public Offering in the United States, Listing on NASDAQ and Share Consolidation
Marketwired - Fri May 15, 4:29PM CDT
Cynapsus Therapeutics Inc. (TSX: CTH)(OTCQX: CYNAF) announced today the filing of a registration statement with the US Securities and Exchange Commission relating to a public offering in the United States of its common shares and the filing of an application to list on the NASDAQ Capital Market. The timing, number of shares and price per share of the proposed offering have not yet been determined. Cynapsus also announced an amendment to the Company's articles to consolidate the issued and outstanding common shares of the Company on the basis of one post-consolidation common share for 16 pre-consolidation common shares to facilitate the proposed listing on NASDAQ, as previously approved by the shareholders of the Company.
CTH.TO: 21.97 (-0.97)

Cynapsus Therapeutics Reports First Quarter 2015 Financial Results and Recent Developments
Marketwired - Fri May 08, 3:46PM CDT
Cynapsus Therapeutics Inc. (TSX: CTH)(OTCQX: CYNAF), a specialty Central Nervous System (CNS) pharmaceutical company developing and preparing to commercialize a fast-acting, easy-to-use sublingual thin film for the on-demand management of debilitating OFF episodes associated with Parkinson's disease (PD), today announced financial results for the three months ended March 31, 2015. Unless specified otherwise, all amounts are in Canadian dollars.
CTH.TO: 21.97 (-0.97)

Cynapsus Therapeutics Announces CAD$21 Million Private Placement
BusinessWire - Tue Mar 31, 9:26AM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson's disease, today announced the completion of a private placement (the "Offering" of 22,039,472 common shares of the Company (the "Common Shares" for gross proceeds of CAD$20,981,579.
CTH.TO: 21.97 (-0.97)

Cynapsus Therapeutics Reports 2014 Annual Results
BusinessWire - Tue Mar 17, 4:56PM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson's disease, today announced financial results for the year ended December 31, 2014. Unless specified otherwise, all amounts are in Canadian dollars.
CTH.TO: 21.97 (-0.97)

Cynapsus to Host Analyst and Investor Breakfast in New York City on March 18
BusinessWire - Mon Mar 16, 5:00AM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on Parkinson's disease, announced that it will host an Analyst and Investor Breakfast featuring presentations by executive management and a clinical key opinion leader on Wednesday, March 18, 2015 at 7:30 a.m. in New York City.
CTH.TO: 21.97 (-0.97)

Cynapsus Therapeutics Appoints Tamar Howson to Board of Directors
BusinessWire - Thu Mar 12, 3:10PM CDT
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on the treatment of OFF episodes in Parkinson's disease, today announced that Tamar Howson has been appointed to the Company's Board of Directors. With the addition of Ms. Howson to the Board of Directors, the Company now has eight directors, with seven directors classified as independent.
OXGN: 0.70 (-0.03), NPSP: 45.97 (+0.01), BMY: 75.06 (-0.50), CTH.TO: 21.97 (-0.97)

Cynapsus Therapeutics Provides Clinical and Regulatory Update for APL-130277 for the Acute Rescue of OFF Motor Symptoms of Parkinson's Disease
BusinessWire - Wed Mar 11, 3:10PM CDT
--Received Final Minutes From End-of-Phase 2 Meeting with U.S. FDA
CTH.TO: 21.97 (-0.97)

Cynapsus Therapeutics Inc. to Present at the D2 2015 - Noble Financial Capital Markets' Eleventh Annual Investor / Equity Conference
BusinessWire - Thu Jan 15, 3:05PM CST
Cynapsus Therapeutics Inc. (TSX:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company, today announced that its President and CEO, Anthony Giovinazzo, will present at the Noble Financial Capital Markets' Eleventh Annual Equity Conference at Club Med in Sandpiper Bay, Florida, on Monday, January 19th at 10:00am Eastern Standard Time in Room 1.
CTH.TO: 21.97 (-0.97)

Cynapsus Therapeutics Announces Uplisting to the Toronto Stock Exchange's Senior Equity Market
BusinessWire - Tue Nov 25, 3:10PM CST
Cynapsus Therapeutics Inc. (TSX-V:CTH) (OTCQX:CYNAF), a specialty pharmaceutical company focused on Parkinson's disease, today announced that its common shares will commence trading on the Toronto Stock Exchange (TSX) as of the opening of trading on Friday, November 28, 2014. The Company's common shares will continue to trade under the symbol "CTH," with its common shares to cease trading on the TSX Venture Exchange concurrent with the commencement of trading on the TSX.

Scroll down for more posts ▼

Top 10 Most Recent News Articles

USPS Honors 150 Years of the U.S. Coast Guard Academy

Updated Category News Views 7

Honoring Tradition and Service The good ol’ U.S. Postal Service is at it again, giving a tip of the hat to a slice of American military heritage. This time, they’re putting out a new stamp to celebrate the 150th anniversary of the U.S. Coast Guard Academy. And you know where they did the honors? Right there on Custom House Pier in New London, Connecticut, a place that...

Continue Reading
PwC US and India Unite for Global Consultancy Powerhouse

Updated Category News Views 3

Rearranging the Consultancy Chessboard Piling onto the game of consultancy realignments, PwC just made a move reminiscent of playing strategy poker. They're tossing together PwC US and PwC India's advisory capabilities for a new joint venture. It’s like pushing two puzzle pieces to make a single colorful picture that stretches from the U.S. all the way to the...

Continue Reading
Damp or Dry: The Battle for Healthy Air in Colorado

Updated Category News Views 5

The Hidden Cost of Colorado's Dry Air Dry climate isn't just a seasonal inconvenience—it's a real hidden cost to living comfortably and healthily in Colorado. With winters colder than a brass monkey's tail and summers that don't offer much relief in terms of humidity, your home's air quality is on the front line. So, what's the financial tale here, and how do you come...

Continue Reading
OneOdio Showcases Innovation at IFA 2026 in Berlin

Updated Category News Views 4

Echoes from Berlin IFA 2026 in Berlin was a cacophony of innovation, as OneOdio wrapped up its showcase with a bang. Boasting interactive activities and live DJ sets, the event echoed OneOdio's drive to meld advanced audio technology with the pulsating needs of music pros and everyday listeners. You couldn’t miss the excitement in the air at Booth 217. Tech Unplugged:...

Continue Reading
Tam-Peli Steps Up in SCLC Battle: Trial Insights

Updated Category News Views 4

Noteworthy Developments in Small-Cell Lung Cancer Treatment Let's dive into a story straight from the world of small-cell lung cancer (SCLC) that doesn't take any prisoners. The antidote making waves is tambotatug pelitecan, or Tam-Peli for short, showcasing its might in the unrelenting fight against relapsed SCLC. The phase III TAISHAN-302 trial puts Tam-Peli...

Continue Reading
Ajman Spotlights Tourism at Arabian Travel Market 2026

Updated Category News Views 3

Ajman: A Tourism Gem in the Making Swinging into the Arabian Travel Market 2026, Ajman isn't just a footnote in the UAE's tourism playbook anymore, it's gunning for the spotlight. There's a flurry of activity as the Ajman Department of Tourism, Culture and Media rolls up its sleeves to flaunt the emirate's kaleidoscope of attractions to the world's tourism brass. Going...

Continue Reading
SMPL Faces Legal Drama: What Investors Need to Know

Updated Category News Views 5

Investors Swim Against the Current With SMPL Picture this: You’re sipping your morning coffee, glancing through stocks, only to choke on your bagel when The Simply Good Foods Company (NASDAQ: SMPL) pops up with some less-than-palatable news. A class action is brewing, shouting out to investors who took the bait from October 24, 2024, to April 8, 2026. If you’re one of...

Continue Reading
U.S. Green Beret's Mission: Clearing Landmines in Ukraine

Updated Category News Views 3

The Rise of "Safe Ground" on Prime Video This isn't your typical feel-good story—it’s about grit and the unending fight for 'normalcy' where war left scars. Safe Ground, now streaming on Prime Video, showcases Ryan Hendrickson, a U.S. Army Green Beret whose story takes a sharp turn after stepping on an IED in 2010. The day he almost became just another statistic...

Continue Reading
PureHealth's Acid Reflux Solutions: An Investor's Insight

Updated Category News Views 3

Digestive Wellness: The Emerging Opportunity Some days, it feels like everybody's got a gripe about their gut. You nod along at the lunch counter, folks buzzing about digestive this and acid that. But when PureHealth Research pops up with their fancy supplements, well, even the stock market's noisier nonsense starts sounding a bit quieter. They're banking big on the...

Continue Reading
Trial Disappointment: No Significant Gains in NSCLC

Updated Category News Views 2

Dissecting the Nuances of the EVOKE-03/KEYNOTE-D46 Trial Every once in a while, we come across a trial that rattles cages in the research community. Today, it's the EVOKE-03/KEYNOTE-D46 trial, a collision of hope and hard-knock reality. This Phase 3 trial, which sought to explore the potential combo of sacituzumab govitecan (SG) and pembrolizumab on metastatic non-small...

Continue Reading

Top 5 Most Recently Viewed Articles

Investigation Into bluebird bio, Inc.’s Acquisition Proposal

Updated Category News Views 167

Understanding the Investigation into bluebird bio, Inc. Recent developments have captured the attention of shareholders and the financial community regarding bluebird bio, Inc. (NASDAQ: BLUE). Rowley Law PLLC has initiated an investigation exploring possible violations of securities law associated with the company’s proposed acquisition. This acquisition is a joint...

Continue Reading
Unwind in Paradise: The Seminyak Beach Resort's Escape

Updated Category News Views 105

Experience Tranquility at The Seminyak Beach Resort & Spa The Seminyak Beach Resort & Spa invites travelers everywhere to immerse themselves in the serene beauty of Bali with its new Seaside Escape package. This luxurious beachfront haven is celebrated for its genuine Balinese artistry and exceptional service, perfectly catering to those who seek a unique blend of...

Continue Reading
Lyte Fiber Launches Advanced Network to Enhance Connectivity

Updated Category News Views 468

Lyte Fiber Unveils Innovative Fiber Network Project Lyte Fiber, LLC is making significant strides in enhancing digital connectivity by initiating construction on its state-of-the-art multi-gigabit fiber network. This investment, amounting to over $11 million, aims to transform the digital landscape for homes and businesses. The company envisions an upgraded digital...

Continue Reading
ONE Gas Boosts Commercial Paper Program for Financial Flexibility

Updated Category News Views 67

ONE Gas Expands Its Commercial Paper Program ONE Gas, Inc. (NYSE: OGS), a prominent natural gas distribution company, has announced a significant increase in the limit of its commercial paper program. This update, disclosed through a recent SEC filing, raises the program's ceiling from $1.275 billion to $1.35 billion, reflecting the company's proactive approach in...

Continue Reading
Sogeclair's Voting Rights Update for Stakeholders in 2025

Updated Category News Views 133

Sogeclair's Insights on Voting Rights and Share Capital SOGECLAIR As a prominent business corporation with a capital of 3,204,901 Euros, Sogeclair is dedicated to maintaining transparency in its operations. The company is headquartered at 7 Avenue Albert Durand, BLAGNAC (France). If you need to reach out, the contact number is +33 (0)5.61.71.71.71 and more about the...

Continue Reading